METRONIDAZOLE by Fosun Pharma is clinical pharmacology absorption disposition of metronidazole in the body is similar for both oral and intravenous dosage forms. Approved for the treatment of asymptomatic t, the treatment of acute intestinal amebiasis (amebic dysentery), amebic liver abscess and 1 more indications. First approved in 1982.
Drug data last refreshed 7h ago · AI intelligence enriched 1w ago
Metronidazole is a small-molecule nitroimidazole antibiotic with bactericidal and trichomonacidal activity used to treat anaerobic bacterial infections, parasitic infections (trichomoniasis, amebiasis), and amebic liver abscess. The drug works by disrupting DNA synthesis in susceptible organisms and exhibits excellent tissue penetration, including into cerebrospinal fluid and hepatic abscess pus.
Product is in LOE-approaching phase with moderate competitive pressure (30%), signaling declining market opportunity and likely downsizing or consolidation of the brand team.
CLINICAL PHARMACOLOGY Absorption Disposition of metronidazole in the body is similar for both oral and intravenous dosage forms. FLAGYL 375 capsules have been shown to have a rate and extent of absorption similar to metronidazole tablets (FLAGYL) and were bioequivalent at an equal single dose of…
Worked on METRONIDAZOLE at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy
Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)
Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
Only 1 linked job identified (IT Technician I) signals minimal active hiring and likely cost-containment posture. Roles available are primarily operational/support rather than commercial or clinical, reflecting mature product lifecycle with limited growth investment.
1 open roles linked to this drug